4.3 Review

Cardiac cell therapy: Current status, challenges and perspectives

期刊

ARCHIVES OF CARDIOVASCULAR DISEASES
卷 113, 期 4, 页码 285-292

出版社

ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.acvd.2020.01.002

关键词

Stem cells; Heart failure; Extracellular vesicles; Tissue engineering

资金

  1. Laboratoire d' Excellence Revive (Investissement d' Avenir) [ANR-10-LABX73]
  2. Fondation de France [FDF/2014 00047970]
  3. Fondation pour la Recherche Medicate (Prix Victor et Erminia Mescle) [PME20180639496]
  4. Fondation de l'Avenir [APRM-18-017]

向作者/读者索取更多资源

Although the initial clinical trials of cardiac cell therapy have failed to demonstrate Stem cells; unequivocal clinical benefits, the accumulation of preclinical data gathered in parallel can now Heart failure; help us to understand the main causes of failures, while providing mechanistic insights that Extracellular may be leveraged to improve the outcomes of subsequent clinical studies using cells or their vesicles; secreted products. This review briefly describes the current status of clinical trials, discusses Tissue engineering the potential mechanisms of action of the grafted cells, and the impact of this knowledge on the design of future studies, and finally draws some perspectives. (C) 2020 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据